Lonza expands partnership with US drugmaker, boosts capacity for ADCs

Contract manufacturing powerhouse Lonza is growing in more ways than one. | Contract manufacturing powerhouse Lonza is growing in more ways than one. The Swiss company revealed this week that it is expanding its capacity to manufacture antibody-drug conjugates—and that it has increased the scope of its partnership with a large, unnamed U.S. drugmaker.